Vitamin E supplementation increases LDL resistance to ex vivo oxidation in hemodialysis patients

Int J Vitam Nutr Res. 2003 Jul;73(4):290-6. doi: 10.1024/0300-9831.73.4.290.

Abstract

Background: Oxidative stress and alterations in lipid metabolism observed in hemodialysis patients potentiate the low-density lipoprotein (LDL) oxidability, recognized as a key event during early atherogenesis.

Objective: To explore the effects of an oral vitamin E supplementation on oxidative stress markers and LDL oxidability in hemodialysis patients.

Methods: Fourteen hemodialysis patients and six healthy volunteers were given oral vitamin E (500 mg/day) for six months. Oxidative stress was assessed using: plasma and lipoprotein vitamin E levels [high-performance liquid chromatography (HPLC) procedure]; thiobarbituric acid reactive substances (TBARS, Yaggi method); and copper-induced LDL oxidation. All parameters were evaluated before initiation of vitamin E supplementation, and at three and six months thereafter.

Results: At baseline, a significantly higher TBARS concentration and a higher LDL oxidability were observed in hemodialysis patients when compared to controls. After six months of vitamin E supplementation, TBARS and LDL oxidability were normalized in hemodialysis patients.

Conclusion: Our data confirm that hemodialysis patients are exposed to oxidative stress and increased susceptibility to ex vivo LDL oxidation. Since oral vitamin E supplementation prevents oxidative stress and significantly increases LDL resistance to ex vivo oxidation, supplementation by natural antioxidants such as vitamin E may be beneficial in hemodialysis patients.

Publication types

  • Clinical Trial

MeSH terms

  • Analysis of Variance
  • Arteriosclerosis / blood
  • Arteriosclerosis / metabolism
  • Arteriosclerosis / prevention & control
  • Chromatography, High Pressure Liquid
  • Chronic Disease
  • Dietary Supplements*
  • Female
  • Follow-Up Studies
  • Humans
  • Lipid Metabolism
  • Lipids / blood
  • Lipoproteins, LDL / chemistry
  • Lipoproteins, LDL / drug effects*
  • Lipoproteins, LDL / metabolism*
  • Male
  • Middle Aged
  • Oxidation-Reduction / drug effects*
  • Oxidative Stress / drug effects
  • Oxidative Stress / physiology
  • Prospective Studies
  • Renal Dialysis*
  • Thiobarbituric Acid Reactive Substances / metabolism
  • Time Factors
  • Vitamin E / administration & dosage
  • Vitamin E / blood
  • Vitamin E / therapeutic use*

Substances

  • Lipids
  • Lipoproteins, LDL
  • Thiobarbituric Acid Reactive Substances
  • oxidized low density lipoprotein
  • Vitamin E